Published in Diabetes on May 01, 1990
Lessons learned from more than 1,000 pancreas transplants at a single institution. Ann Surg (2001) 1.89
Glucagon, catecholamine and pancreatic polypeptide secretion in type I diabetic recipients of pancreas allografts. J Clin Invest (1990) 1.26
Portal venous and enteric exocrine drainage versus systemic venous and bladder exocrine drainage of pancreas grafts: clinical outcome of 40 consecutive transplant recipients. Ann Surg (2000) 1.14
{beta}-Cell secretory capacity and demand in recipients of islet, pancreas, and kidney transplants. J Clin Endocrinol Metab (2010) 1.04
Results of pancreas transplantation with portal venous and enteric drainage. Ann Surg (1995) 0.98
Pancreas transplantation. An initial experience with systemic and portal drainage of pancreatic allografts. Ann Surg (1992) 0.92
Recovery of endocrine function after islet and pancreas transplantation. Curr Diab Rep (2012) 0.85
Superiority of portal venous drainage over systemic venous drainage in pancreas transplantation: a retrospective study. Ann Surg (2001) 0.81
Pancreas and islet cell transplantation. Best Pract Res Clin Gastroenterol (2002) 0.78
Time-related, cross-sectional and prospective follow-up of pancreatic endocrine function after pancreas allograft transplantation in type 1 (insulin-dependent) diabetic patients. Diabetologia (1991) 0.77
Hyperinsulinemia after pancreatic transplantation. Prediction by a novel computer model and in vivo verification. Ann Surg (1993) 0.77
Combined pancreas and kidney transplantation normalizes protein metabolism in insulin-dependent diabetic-uremic patients. J Clin Invest (1994) 0.76
Consequences of systemic venous drainage and denervation of heterotopic pancreatic transplants for insulin/C-peptide profiles in the basal state and after oral glucose. Diabetologia (1991) 0.76
Pathophysiology of hyperinsulinemia following pancreas transplantation: altered pulsatile versus Basal insulin secretion and the role of specific transplant anatomy in dogs. Ann Surg (2002) 0.75
Diabetes and other endocrine-metabolic abnormalities in the long-term follow-up of pancreas transplantation. Clin Diabetes Endocrinol (2016) 0.75
Metabolic and hormonal studies of type 1 (insulin-dependent) diabetic patients after successful pancreas and kidney transplantation. Diabetologia (1991) 0.75
Insulin action and insulin binding following pancreas transplantation. Diabetologia (1991) 0.75
Treatment of diabetes mellitus. Diabetologia (1992) 0.75
Structural-functional relationships in diabetic nephropathy. J Clin Invest (1984) 4.78
Reversal of lesions of diabetic nephropathy after pancreas transplantation. N Engl J Med (1998) 4.30
Evaluation of chloramphenicol and ampicillin in salmonella enteric fever. N Engl J Med (1968) 2.41
The impact of cyclosporine and combination immunosuppression on the incidence of posttransplant diabetes in renal allograft recipients. Transplantation (1987) 2.40
Relationships between fasting plasma glucose levels and insulin secretion during intravenous glucose tolerance tests. J Clin Endocrinol Metab (1976) 2.39
Effects of pancreatic transplantation on diabetic neuropathy. N Engl J Med (1990) 2.32
Immunologic and nonimmunologic factors: different risks for cadaver and living donor transplantation. Transplantation (2000) 2.25
A mammalian equivalent of the avian bursa of Fabricius. Lancet (1966) 2.11
Long-term effects of pancreatic transplantation on diabetic neuropathy. Ann Neurol (1997) 2.09
Development of "autoimmune processes" in rabbits after neonatal removal of central lymphoid tissue. Lancet (1965) 2.04
Prevention of glucose toxicity in HIT-T15 cells and Zucker diabetic fatty rats by antioxidants. Proc Natl Acad Sci U S A (1999) 1.94
Lessons learned from more than 1,000 pancreas transplants at a single institution. Ann Surg (2001) 1.89
Vascular graft thrombosis after pancreatic transplantation: univariate and multivariate operative and nonoperative risk factor analysis. J Am Coll Surg (1996) 1.83
Chronic exposure of HIT cells to high glucose concentrations paradoxically decreases insulin gene transcription and alters binding of insulin gene regulatory protein. J Clin Invest (1993) 1.81
Recurrent diabetes mellitus in the pancreas iso- and allograft. A light and electron microscopic and immunohistochemical analysis of four cases. Lab Invest (1985) 1.80
The surgical risk of pancreas transplantation in the cyclosporine era: an overview. J Am Coll Surg (1997) 1.79
Intra-abdominal fungal infections after pancreatic transplantation: incidence, treatment, and outcome. J Am Coll Surg (1996) 1.75
Studies of the rate of regression of the glomerular lesions in diabetic rats treated with pancreatic islet transplantation. Diabetes (1975) 1.74
Preserved insulin secretion and insulin independence in recipients of islet autografts. N Engl J Med (1992) 1.74
Effects of pancreas transplantation on glomerular structure in insulin-dependent diabetic patients with their own kidneys. Lancet (1993) 1.70
Prenatal phthalate exposure and reduced masculine play in boys. Int J Androl (2009) 1.69
Hepatocellular transplantation for metabolic deficiencies: decrease of plasms bilirubin in Gunn rats. Science (1976) 1.65
Progression of diabetic retinopathy after pancreas transplantation for insulin-dependent diabetes mellitus. N Engl J Med (1988) 1.65
Hepatic resection for secondary neoplasms. Surgery (1982) 1.64
Chronic treatment with phentermine combined with fenfluramine lowers plasma serotonin. Am J Cardiol (2000) 1.58
Effects of hemipancreatectomy on insulin secretion and glucose tolerance in healthy humans. N Engl J Med (1990) 1.53
The glucose receptor. A defective mechanism in diabetes mellitus distinct from the beta adrenergic receptor. J Clin Invest (1973) 1.53
Pancreatitis and hyperparathyroidism. Br J Surg (1988) 1.52
The reduction of insulin gene transcription in HIT-T15 beta cells chronically exposed to high glucose concentration is associated with the loss of RIPE3b1 and STF-1 transcription factor expression. Mol Endocrinol (1995) 1.52
Improved islet isolation from rat pancreas using 35% bovine serum albumin in combination with Dextran gradient separation. Transplantation (1996) 1.51
Cell and matrix components of the glomerular mesangium in type I diabetes. Diabetes (1992) 1.51
Rotation of the anatomic regions used for insulin injections and day-to-day variability of plasma glucose in type I diabetic subjects. JAMA (1990) 1.50
Colon perforation after renal transplantation: a single-institution review. Clin Transplant (1997) 1.47
Prolonged preservation increases surgical complications after pancreas transplants. Surgery (2000) 1.44
Pancreas after kidney transplants. Am J Surg (2001) 1.44
Fractionated total lymphoid irradiation as preparative immunosuppression in high risk renal transplantation: clinical and immunological studies. Ann Surg (1982) 1.44
Intra-abdominal infections in pancreas transplant recipients. Ann Surg (1986) 1.42
2,500 living donor kidney transplants: a single-center experience. Ann Surg (2001) 1.41
The glomerular mesangium. 3. Acute immune mesangial injury: a new model of glomerulonephritis. J Exp Med (1973) 1.40
[Gougerot-Sjögren syndrome associated with dysthyroidism]. Rev Rhum Mal Osteoartic (1990) 1.38
A secondary case of meningococcal disease in an ambulance worker, Berkshire, November 2007. Euro Surveill (2008) 1.38
Insulin secretion and cAMP metabolism in HIT cells. Reciprocal and serial passage-dependent relationships. Diabetes (1989) 1.38
Autologous islet transplantation to prevent diabetes after pancreatic resection. Ann Surg (1995) 1.37
Cyclosporin A in renal transplantation: a prospective randomized trial. Surgery (1982) 1.36
The effects of pancreas transplantation on the glomerular structure of renal allografts in patients with insulin-dependent diabetes. N Engl J Med (1989) 1.35
Colon ulceration in lethal cytomegalovirus infection. Am J Clin Pathol (1981) 1.34
Total or near total pancreatectomy and islet autotransplantation for treatment of chronic pancreatitis. Ann Surg (1980) 1.34
Human islet autotransplantation following pancreatectomy. Transplant Proc (1979) 1.30
Adrenergic modulation of basal insulin secretion in man. Diabetes (1973) 1.29
Successful islet autotransplantation in humans: functional insulin secretory reserve as an estimate of surviving islet cell mass. Diabetes (1998) 1.29
Pancreatic islet cell transplantation. Surg Clin North Am (1978) 1.28
Pancreas transplantation in the United States (US) and non-US as reported to the United Network for Organ Sharing (UNOS) and the International Pancreas Transplant Registry (IPTR). Clin Transpl (1996) 1.28
Chronic exposure of betaTC-6 cells to supraphysiologic concentrations of glucose decreases binding of the RIPE3b1 insulin gene transcription activator. J Clin Invest (1996) 1.28
Control of insulin secretion by catecholamines, stress, and the sympathetic nervous system. Fed Proc (1973) 1.28
Pancreatic endocrine function in cystic fibrosis. J Pediatr (1991) 1.28
Duodenal complications in bladder-drained pancreas transplantation. Surgery (1997) 1.27
Seven years' experience with antilymphoblast globulin for renal transplantation from cadaver donors. Ann Surg (1976) 1.26
Glucagon, catecholamine and pancreatic polypeptide secretion in type I diabetic recipients of pancreas allografts. J Clin Invest (1990) 1.26
Differential roles of Mac-1+ cells, and CD4+ and CD8+ T lymphocytes in primary nonfunction and classic rejection of islet allografts. J Exp Med (1990) 1.23
Differences in rejection grading after simultaneous pancreas and kidney transplantation in pigs. Transplantation (1994) 1.22
Pancreas transplantation. An immunohistologic and histopathologic examination of 100 grafts. Am J Pathol (1987) 1.21
Short- and long-term outcomes of kidney transplants with multiple renal arteries. Ann Surg (1995) 1.21
Effects of hemipancreatectomy on pancreatic alpha and beta cell function in healthy human donors. J Clin Invest (1992) 1.20
One hundred pancreas transplants at a single institution. Ann Surg (1984) 1.20
Effect of initial slow graft function on renal allograft rejection and survival. Clin Transplant (1997) 1.19
A role for alpha-adrenergic receptors in abnormal insulin secretion in diabetes mellitus. J Clin Invest (1976) 1.19
Quantitative glomerular morphology of the normal human kidney. Lab Invest (1983) 1.18
Human islet transplantation: a preliminary report. Transplant Proc (1977) 1.18
Sequential renal biopsies in insulin-dependent diabetic patients: structural factors associated with clinical progression. Kidney Int (1995) 1.17
Production of an antibody deficiency syndrome in rabbits by neonatal removal of organized intestinal lymphoid tissues. Int Arch Allergy Appl Immunol (1968) 1.16
Morphology of cyclosporine nephrotoxicity and acute rejection in patients immunosuppressed with cyclosporine and prednisone. Surgery (1983) 1.16
Lipoxygenase pathway in islet endocrine cells. Oxidative metabolism of arachidonic acid promotes insulin release. J Clin Invest (1983) 1.16
Prevalence of major depression, simple phobia, and other psychiatric disorders in patients with long-standing type I diabetes mellitus. Arch Gen Psychiatry (1988) 1.16
A single institution, randomized, prospective trial of cyclosporin versus azathioprine-antilymphocyte globulin for immunosuppression in renal allograft recipients. Ann Surg (1985) 1.15
Twin-to-twin pancreas transplantation: reversal and reenactment of the pathogenesis of type I diabetes. Trans Assoc Am Physicians (1984) 1.15
Insulin-secreting cell lines: classification, characteristics and potential applications. Diabetes Metab (1996) 1.15
Mean glomerular volume and rate of development of diabetic nephropathy. Diabetes (1989) 1.14
A multicenter analysis of the first experience with FK506 for induction and rescue therapy after pancreas transplantation. Transplantation (1996) 1.14
A role for prostaglandin E in defective insulin secretion and carbohydrate intolerance in diabetes mellitus. J Clin Invest (1977) 1.14
Decreased surgical risks of pancreas transplantation in the modern era. Ann Surg (2000) 1.14
Receptor-mediated adenylate cyclase-coupled mechanism for PGE2 inhibition of insulin secretion in HIT cells. Diabetes (1987) 1.13
Determinants of glucose toxicity and its reversibility in the pancreatic islet beta-cell line, HIT-T15. Am J Physiol Endocrinol Metab (2000) 1.13
Pancreas and islet transplantation for patients with diabetes. Diabetes Care (2000) 1.13
Hepatocellular transplantation in acute liver failure. Surgery (1977) 1.12
Neuropathy profile of diabetic patients in a pancreas transplantation program. Neurology (1995) 1.12
The effect of pancreas transplantation on diabetic polyneuropathy. Transplantation (1988) 1.12
Pancreas transplantation. Surg Clin North Am (1986) 1.12
Ketoconazole, cyclosporin metabolism, and renal transplantation. Lancet (1982) 1.12
Living-related donor segmental pancreatectomy for transplantation. Transplant Proc (1980) 1.11
Immunologic factors: the major risk for decreased long-term renal allograft survival. Transplantation (1999) 1.11
Insulin independence in type I diabetes after transplantation of unpurified islets from single donor with 15-deoxyspergualin. Lancet (1993) 1.11